Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1998
10/01/1998WO1998042723A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
10/01/1998WO1998042722A1 Antisense inhibition of angiogenin expression
10/01/1998WO1998042391A1 Process for stimulating neural regeneration
10/01/1998WO1998042381A1 Immobilized activity stabilized lhrh antagonist complexes, method for the production thereof
10/01/1998WO1998042378A1 Immunotherapy of b-cell malignancies using anti-cd22 antibodies
10/01/1998WO1998042377A1 Preventives or remedies for sensitized t cell-related diseases containing il-6 antagonists as the active ingredient
10/01/1998WO1998042371A1 New application for antithrombin iii
10/01/1998WO1998042369A1 Bile secretagogues
10/01/1998WO1998042368A1 Therapeutic powder formulation for pulmonary administration, containing crystalline insulin
10/01/1998WO1998042367A1 Method for preparation of a therapeutic powder through coprecipitation of insulin and absorption enhancer
10/01/1998WO1998042366A1 The use of proteins extractable from animal organs for the preparation of medicaments for the treatment of pathological conditions characterized by hyperproduction of tumor necrosis factor (tnf)
10/01/1998WO1998042365A1 Ligand/lytic peptide compositions and methods of use
10/01/1998WO1998042364A1 Ligand/lytic peptide compositions and methods of use
10/01/1998WO1998042363A1 Immunopotentiators
10/01/1998WO1998042362A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
10/01/1998WO1998042361A1 Human erectile dysfunction and methods of treatment
10/01/1998WO1998042360A1 Modulation of vascular healing by inhibition of leukocyte adhesion and function
10/01/1998WO1998042358A1 Methods for treating vascular disorders
10/01/1998WO1998042354A1 Chemokines that inhibit immunodeficiency virus infection and methods based thereon
10/01/1998WO1998042342A1 Thrombin inhibitors
10/01/1998WO1998042313A1 Opthalmic non-irritating iodine medicament and method
10/01/1998WO1998042296A2 Compositions and methods for diagnosing/treating disease based on beta-catenin/transcription factor interactions
10/01/1998WO1998042275A1 Method of treatment of migraine
10/01/1998WO1998042270A1 Bone marrow as a site for transplantation
10/01/1998WO1998042195A1 Replication-competent herpes simplex viruses
10/01/1998WO1998042188A1 Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases
10/01/1998WO1998032825A3 Photochemical singlet oxygen generators having enhanced singlet oxygen yields
10/01/1998WO1998029555A3 Cytopathic viruses for therapy and prophylaxis of neoplasia
10/01/1998WO1998029131A3 Aqueous glycerol formulations of somatotropin
10/01/1998WO1998027962A3 Injectable depot gel composition and method of preparing the composition
10/01/1998WO1998027206A3 POLYPEPTIDES OF THE 'BASIC-HELIX-LOOP-HELIX' bHLH FAMILY, CORRESPONDING NUCLEIC ACID SEQUENCES
10/01/1998WO1998024913A3 Method and reagent for the treatment of a disease associated with interleukin-2 receptor gamma-chain expression
10/01/1998WO1998024896A3 Muteins of obese protein
10/01/1998WO1998024811A3 Vascular endothelial growth factor
10/01/1998WO1998022580A3 Bovine lactation associated immunotropic protein (cd14), encoding gene and application in b cell activation
10/01/1998WO1998021314A3 Method of promoting B-cell proliferation and activation and of modulating the immune system
10/01/1998WO1998021239A3 Therapeutic compositions and methods and diagnostic assays for type ii diabetes involving hnf-1
10/01/1998DE19727814C1 Monoclonal antibody specific for human tyrosine kinase receptor protein
10/01/1998DE19713001A1 Graminaenpollenallergenmutanten zur spezifischen Immuntherapie, deren Herstellung und Verwendung Graminaenpollenallergenmutanten for specific immunotherapy, their preparation and use
10/01/1998DE19712718A1 Immobilisierte und aktivitätsstabilisierte Komplexe von LHRH-Antagonisten und Verfahren zu deren Herstellung Immobilized and activity-stabilized complexes of LHRH antagonists and methods for their preparation
10/01/1998DE19712530A1 Neue Monomerbausteine zur Markierung von peptidischen Nukleinsäuren New monomer to mark peptide nucleic acids
10/01/1998CA2288613A1 Liposomes containing oligonucleotides
10/01/1998CA2288198A1 Modulation of vascular healing by inhibition of leukocyte adhesion and function
10/01/1998CA2287156A1 Rapid production of autologous tumor vaccines by using hsv amplicon vectors
10/01/1998CA2287082A1 Iron hydrolyzates of casein complexes and processes for preparation thereof
10/01/1998CA2285702A1 Anticoagulant fusion protein anchored to cell membrane
10/01/1998CA2285694A1 Process for preparing obesity protein analogs
10/01/1998CA2285554A1 Secreted proteins and polynucleotides encoding them
10/01/1998CA2285480A1 Screening method for proline-rich proteins
10/01/1998CA2285394A1 Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases
10/01/1998CA2285178A1 Bone marrow as a site for transplantation
10/01/1998CA2285017A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
10/01/1998CA2285015A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
10/01/1998CA2285013A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
10/01/1998CA2285011A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
10/01/1998CA2284820A1 A new use of antithrombin iii
10/01/1998CA2284696A1 Opthalmic non-irritating iodine medicament and method
10/01/1998CA2284687A1 Keratinocyte derived kallikrein
10/01/1998CA2284685A1 Noey2 gene compositions and methods of use
10/01/1998CA2284642A1 Methods and compositions for diagnosis and treatment of breast cancer
10/01/1998CA2284633A1 Chemokines that inhibit immunodeficiency virus infection and methods based thereon
10/01/1998CA2284611A1 Replication-competent herpes simplex viruses
10/01/1998CA2284550A1 87 human secreted proteins
10/01/1998CA2284548A1 The use of proteins extractable from animal organs for the preparation of medicaments for the treatment of pathological conditions characterized by hyperproduction of tumor necrosis factor (tnf)
10/01/1998CA2284279A1 Methods for treating vascular disorders
10/01/1998CA2284251A1 Compounds and methods for the diagnosis and treatment of ehrlichia infection
10/01/1998CA2284105A1 Synthetic saposin c-derived neurotrophic peptides
10/01/1998CA2284095A1 Bi- or multifunctional molecules based on a dendroaspin scaffold
10/01/1998CA2283932A1 Compositions and methods for diagnosing/treating disease based on beta-catenin/transcription factor interactions
10/01/1998CA2283794A1 Vp22 proteins and uses thereof
10/01/1998CA2283792A1 Peptides for the treatment of systemic lupus erythematosus
10/01/1998CA2283705A1 Zinc free insulin crystals for use in pulmonary compositions
10/01/1998CA2283704A1 Thrombin inhibitors
10/01/1998CA2283631A1 Secreted proteins and polynucleotides encoding them
10/01/1998CA2282684A1 Process for stimulating neural regeneration
10/01/1998CA2282410A1 Monoclonal antibodies to human cd6
10/01/1998CA2282275A1 Method of treatment of migraine
10/01/1998CA2256599A1 Iron-casein complex and process for preparing the same
10/01/1998CA2255765A1 Antigenic fusionprotein carrying gal.alpha.1,3gal epitopes
10/01/1998CA2247075A1 Interferon related protein hkafe42
10/01/1998CA2233783A1 Anti-fas antibodies
09/1998
09/30/1998EP0867513A2 Interleukin-1 beta converting enzyme apoptosis protease-10
09/30/1998EP0867510A1 Method of preparing plasmid having both expressing ability of retroviral gene and processing ability after translation, and resultant plasmid and expression products thereof
09/30/1998EP0867509A2 Tumor necrosis related receptor, TR5
09/30/1998EP0867508A2 Olfactory receptor of the 7-transmembrane receptor family - OLRCC15 receptor
09/30/1998EP0867507A1 LicB polypeptides from Streptococcus pneumoniae
09/30/1998EP0867451A2 Monoclonal antibodies reactive with defined regions of the T cell antigen receptor
09/30/1998EP0867450A1 Novel peptide
09/30/1998EP0867449A1 Cell adhesion protein, immunosuppressive agent containing the same, and immunosuppressive agent containing cells induced thereby
09/30/1998EP0867448A1 PEPTIDE SUPPRESSING IxB$g(a) PHOSPHORYLATION
09/30/1998EP0867438A1 Rapamycin derivatives and their use, particularly as immunosuppressants
09/30/1998EP0867189A2 Monoclonal antibodies reactive with defined regions of the T cell antigen receptor
09/30/1998EP0866871A1 Compositions and method for stimulating antibody release by b lymphocytes
09/30/1998EP0866870A1 TISSUE FACTOR - KUNITZ DOMAIN FUSION PROTEINS AS FACTOR VIIa INHIBITORS
09/30/1998EP0866867A2 Adenosine kinase polynucleotides
09/30/1998EP0866865A1 Chimeric oligomers having an rna-cleavage activity
09/30/1998EP0866864A2 Antifungal proteins
09/30/1998EP0866863A1 Antifungal proteins
09/30/1998EP0866861A2 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands
09/30/1998EP0866860A2 Novel tyrosine kinase receptors and ligands
1 ... 2587 2588 2589 2590 2591 2592 2593 2594 2595 2596 2597 2598 2599 2600 2601 2602 2603 2604 2605 2606 2607 ... 3163